Cargando…

Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders

Brain-derived neurotrophic factor (BDNF) is a key modulator of neuroplasticity and has an important role in determining the susceptibility to severe psychiatric disorder with a significant neurodevelopmental component such as major psychoses. Indeed, a potential association between BDNF serum levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manchia, Mirko, Isayeva, Ulker, Collu, Roberto, Primavera, Diego, Deriu, Luca, Caboni, Edoardo, Iaselli, Maria Novella, Sundas, Davide, Tusconi, Massimo, Pinna, Federica, Paribello, Pasquale, Scherma, Maria, Pisanu, Claudia, Meloni, Anna, Zai, Clement C., Congiu, Donatella, Squassina, Alessio, Fratta, Walter, Fadda, Paola, Carpiniello, Bernardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775399/ https://www.ncbi.nlm.nih.gov/pubmed/36552127 http://dx.doi.org/10.3390/brainsci12121666

Ejemplares similares

Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients
por: Isayeva, Ulker, et al.
Publicado: (2022)

Exploring the association between brain-derived neurotrophic factor (BDNF) levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients
por: Isayeva, U., et al.
Publicado: (2022)

Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study
por: Primavera, Diego, et al.
Publicado: (2017)

Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review
por: Paribello, Pasquale, et al.
Publicado: (2023)

Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease
por: Manchia, Mirko, et al.
Publicado: (2019)

Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective
por: Carta, Andrea, et al.
Publicado: (2022)

Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder
por: Pisanu, Claudia, et al.
Publicado: (2022)

Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis
por: Paribello, Pasquale, et al.
Publicado: (2023)

Challenges and Future Prospects of Precision Medicine in Psychiatry
por: Manchia, Mirko, et al.
Publicado: (2020)

Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study
por: Fellendorf, Frederike T., et al.
Publicado: (2022)

Exploring the association among the tryptophan to serotonin and kynurenine pathways, cognition and suicidal behaviour: a secondary analysis in a sample of individuals affected by Bipolar Disorder.
por: Paribello, P., et al.
Publicado: (2023)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
por: Fontana, Andrea, et al.
Publicado: (2020)

Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics
por: Manchia, Mirko, et al.
Publicado: (2021)

The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review
por: Pinna, Federica, et al.
Publicado: (2020)

Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature
por: Paribello, Pasquale, et al.
Publicado: (2021)

Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies
por: Fellendorf, Frederike T., et al.
Publicado: (2023)

Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence
por: Paribello, Pasquale, et al.
Publicado: (2022)

The Role of Gut Microbiota in the High-Risk Construct of Severe Mental Disorders: A Mini Review
por: Sani, Gabriele, et al.
Publicado: (2021)

Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders
por: Pinna, Federica, et al.
Publicado: (2015)

Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa
por: Scherma, Maria, et al.
Publicado: (2023)

A multidisciplinary approach to mental illness: do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders
por: Manchia, Mirko, et al.
Publicado: (2020)

Cannabinoids and their therapeutic applications in mental disorders 
por: Scherma, Maria, et al.
Publicado: (2020)

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
por: Melas, Philippe A., et al.
Publicado: (2021)

New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
por: Scherma, Maria, et al.
Publicado: (2018)

Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa
por: Dedoni, Simona, et al.
Publicado: (2023)

Gender Differences in Remission and Recovery of Schizophrenic and Schizoaffective Patients: Preliminary Results of a Prospective Cohort Study
por: Carpiniello, Bernardo, et al.
Publicado: (2012)

Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy
por: Pinna, Federica, et al.
Publicado: (2015)

Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders
por: Pinna, Federica, et al.
Publicado: (2013)

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
por: Dedoni, Simona, et al.
Publicado: (2022)

Clinicians’ adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness
por: Manchia, Mirko, et al.
Publicado: (2017)

Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets
por: Piras, Ignazio S, et al.
Publicado: (2018)

Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis
por: Fico, Giovanna, et al.
Publicado: (2023)

Genetic and Epigenetic Markers of Lithium Response
por: Pisanu, Claudia, et al.
Publicado: (2022)

Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female Rats
por: Satta, Valentina, et al.
Publicado: (2018)

Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder
por: Squassina, Alessio, et al.
Publicado: (2010)

Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment
por: Squassina, Alessio, et al.
Publicado: (2022)

Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy
por: Manchia, Mirko, et al.
Publicado: (2020)

Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review
por: Ghandour, Fatima, et al.
Publicado: (2021)

Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive Therapy
por: Pisanu, Claudia, et al.
Publicado: (2021)

Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence
por: Qvist, Johanna S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k2bk209gvom40lkcfl03100okt